Literature DB >> 8787816

Induction of HSP-70 after hyperosmotic opening of the blood-brain barrier in the rat.

J D Richmon1, K Fukuda, F R Sharp, L J Noble.   

Abstract

The cellular response resulting from breakdown of the blood-brain barrier was evaluated 24 h after hyperosomotic infusion of mannitol into the internal carotid artery in the rat. Heat shock protein (HSP-70), a marker of cellular stress and/or injury, was induced in scattered patches of neurons and glia in regions of barrier breakdown. These findings suggest that osmotically induced breakdown of the blood-brain barrier may result in cell injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787816     DOI: 10.1016/0304-3940(95)12208-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats.

Authors:  V Rousseau; B Denizot; D Pouliquen; P Jallet; J J Le Jeune
Journal:  MAGMA       Date:  1997-09       Impact factor: 2.310

3.  Heat shock treatment protects osmotic stress-induced dysfunction of the blood-brain barrier through preservation of tight junction proteins.

Authors:  Tzong-Shi Lu; Hsiang-Wen Chen; Maw-Hsiung Huang; Shu-Jung Wang; Rei-Cheng Yang
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

4.  Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways.

Authors:  S G Gray; A H Iglesias; B T Teh; F Dangond
Journal:  Gene Expr       Date:  2003

5.  A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD).

Authors:  Ronit Shaltiel-Karyo; Moran Frenkel-Pinter; Edward Rockenstein; Christina Patrick; Michal Levy-Sakin; Abigail Schiller; Nirit Egoz-Matia; Eliezer Masliah; Daniel Segal; Ehud Gazit
Journal:  J Biol Chem       Date:  2013-05-01       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.